mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.6 |
mRNA |
BRD-K44224150 |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.6 |
mRNA |
FQI-2 |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.6 |
mRNA |
salermide |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.6 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.6 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
LY-2157299 |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.6 |
mRNA |
WP1130 |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |